HCPCS Level IIdrugActive
J1440
Fecal microbiota jslm 1 ml
BETOS: T2D
Effective: 2023-07-01
Referenced in 1 policies
Description
Fecal microbiota, live - jslm, 1 ml
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Rebyota
Manufacturer
Ferring Pharmaceuticals Inc.
HCPCS Dosage
1 ML
Billing Units
150.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.